BDX vs BMY
Becton Dickinson vs Bristol Myers Squibb — AI-powered side-by-side comparison
| Metric | BDX | BMY |
|---|---|---|
| AI Score | 56 | 57 |
| Price | $159.87 | $60.52 |
| P/E Ratio | 40.49× | 17.00× |
| ROE | 0.1% | 0.4% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.5% | 0.7% |
| Debt / Equity | 0.72× | 2.22× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 57.6 | 57.1 |
| Beta | 0.271 | 0.235 |
| Expected Upside | +26.1% | +2.6% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BDX Full Analysis
BMY Full Analysis